
Children with eczema: the link to food allergies is not clear cut
May 02, 2019 16:47 pm UTC| Health
Around one in five children have eczema and even mild cases can have a big impact on both the child and their family. For many, symptoms will come and go before they start primary school, but for others it can indicate...
Psychedelics to treat mental illness? Australian researchers are giving it a go
Apr 27, 2019 06:21 am UTC| Insights & Views Health
An estimated one in ten Australians were taking antidepressants in 2015. Thats double the number using them in 2000, and the second-highest rate of antidepressant use among all OECD countries. Yet some studies have...
Apr 27, 2019 06:20 am UTC| Insights & Views Health
The question of whether personality is the result of nature or nurture has plagued researchers and the general public for decades. What we do know is that we are all unique, each with a distinctive pattern of speech,...
Striving for happiness could be making you unhappy – here’s how to find your own path
Apr 27, 2019 06:17 am UTC| Insights & Views Health
Happiness is big business, with sales of self-help books in the UK reaching record levels in the past year. Perhaps thats because happiness is no longer the birthright of the elite. Just half a century ago, psychologist...
Parkinson's: four unusual signs you may be at risk
Apr 27, 2019 06:09 am UTC| Insights & Views Health
Do you move around a lot during your sleep? Or have you lost your sense of smell? New insights into Parkinsons disease suggest that these might be the early signs of changes in the brain that mean you are at greater risk...
How your employer uses perks like wellness programs, phones and free food to control your life
Apr 27, 2019 06:08 am UTC| Insights & Views Health
Companies offer all sorts of benefits and extras to attract the most favored workers, from health care and stock options to free food. But all those perks come at a price: your freedom. Theres a reason labor historians...
No cure for Alzheimer's disease in my lifetime
Apr 27, 2019 06:08 am UTC| Insights & Views Health
Biogen recently announced that it was abandoning its late stage drug for Alzheimers, aducanumab, causing investors to lose billions of dollars. They should not have been surprised. Not only have there been more than...